References - Therapeutic Strategies in Cancer Biology and Pathology - page 261

Ying, S., Hamdy, F.C., Helleday, T., 2012. Mre11-dependent degradation of stalled DNA rep-
lication forks is prevented by BRCA2 and PARP1. Cancer Res. 72, 2814-2821.
Yokosaki, Y., Tanaka, K., Higashikawa, E., Yamashita, K., Eboshida, A., 2005. Distinct struc-
tural requirement for binding fo the integrins alphavbeeta6, alphavbeeta5, alpha5beta1
and alpha9beta1 to osteopontin. Matrix Biol. 24, 418-427.
Yoo, B.K., Gredler, R., Chen, D., Santhekadur, P.K., Fisher, P.B., Sarkar, D., 2011. c-Met acti-
vation through a novel pathway involving osteopontin mediates oncogenesis by the tran-
scription factor LSF. J. Hepatol. 55, 1317-1324.
Yook, J.I., Li, X.Y., Ota, I., Fearon, E.R., Weiss, S.J., 2005. Wnt-dependent regulation of the
E-cadherin repressor snail. J. Biol. Chem. 280, 11740-11748.
Yook, J.I., Li, X.Y., Ota, I., Hu, C., Kim, H.S., Kim, N.H., et al., 2006. A Wnt-Axin2-GSK3beta
cascade regulates Snail1 activity in breast cancer cells. Nat. Cell Biol. 8, 1398-1406.
Yoon, B.C., Zivraj, K.H., Strochlic, L., Holt, C.E., 2012. 14-3-3 proteins regulate retinal axon
growth by modulating ADF/cofilin activity. Develop. Neurobiol. 72, 600-614.
Yoon, C.S., Hyung, W.J., Lee, J.H., Chae, Y.S., Won, N.H., Yeom, B.W., et al., 2008.
Expression of S100A4, E-cadherin, alpha- and beta-catenin in gastric adenocarcinoma.
Hepatogastroenterology 55, 1916-1920.
Yoshida, B.A., Dubauskas, Z., Chekmareva, M.A., Christiano, T.R., Stadler, W.M., Rinker-
Schaeffer, C.W., 1999. Mitogen-activated protein kinase kinase 4/stress-activated protein/
Erk kinase 1 (MKK4/SEK1), a prostate cancer metastasis suppressor gene encoded by
human chromosome 17. Cancer Res. 59, 5483-5487.
Yoshizawa, K., Nozaki, S., Kitahara, H., Kato, K., Noguchi, N., Kawashiri, S., et al., 2011.
Expression of urokinase-type plasminogen activator/urokinase-type plasminogen activa-
tor receptor and maspin in oral squamous cell carcinoma: association with mode of inva-
sion and clinicopathological factors. Oncol. Rep. 26, 1555-1560.
Young, J.A., Collier, R.J., 2007. Anthrax toxin: receptor binding, internalization, pore forma-
tion, and translocation. Annu. Rev. Biochem. 76, 243-265.
Yu, F., Jiao, Y., Zhu, Y., Wang, Y., Zhu, J., Cui, X., et al., 2012a. MicroRNA 34c gene down-
regulation via DNA methylation promotes self-renewal and epithelial-mesenchymal tran-
sition in breast tumor-initiating cells. J. Biol. Chem. 287, 465-473.
Yu, J., Zheng, Y., Dong, J., Klusza, S., Deng, W.M., Pan, D., 2010. Kibra functions as a
tumor suppressor protein that regulates Hippo signalling in conjunction with Merlin and
Expanded. Dev. Cell 18, 288-299.
Yu, L., Li, H.Z., Lu, S.M., Tian, J.J., Ma, J.K., Wang, H.B., et al., 2011. Down-regulation
of TWIST decreases migration and invasion of laryngeal carcinoma Hep-2 cells by
regulating the E-cadherin, N-cadherin expression. J. Cancer Res. Clin. Oncol. 137,
1487-1493.
Yu, L., Lu, S., Tian, J., Ma, J., Li, J., Wang, H., et al., 2012b. TWIST expression in
hypopharyngeal cancer and the mechanism of TWIST-induced promotion of metastasis.
Oncol. Rep. 27, 416-422.
Yu, S.W., Wang, H., Poitras, M.F., et al., 2002. Mediation of poly(ADP-ribose) polymerase-
1-dependent cell death by apoptosis-inducing factor. Science 297, 259-263.
Yuan, B.Z., Zhou, X.L., Durkin, M.E., Zimonjic, D.B., Gumundsdottir, K., Eyfjord, J.E.,
et al., 2003a. DLC-1 gene inhibits human breast cancer cell growth and in vivo tumori-
genicity. Oncogene 22, 445-450.
Yuan, B.Z., Durkin, M.E., Popescu, N.C., 2003b. Promoter hypermethylation of DLC-1,
a candidate tumor suppressor gene, in several common human cancers. Cancer Genet.
Cytogenet. 140, 113-117.